Buy Mitomycin 40 Mitomycin Injection IP 40 mg

Mitomycin Injection IP 40 mg is a chemotherapy medication used to treat certain types of cancer. It belongs to the class of antitumor antibiotics and is administered via injection. This 40 mg strength vial is commonly used in clinical settings for targeted therapy. Short-term use under medical supervision is typical.

Strength

40mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Naprod Lifesciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Mitomycin 40 mg is primarily used to treat cancers such as bladder cancer, stomach cancer, and pancreatic cancer. It may also be used in combination therapies for other solid tumors. The medication works by slowing or stopping cancer cell growth. Patients often ask, 'what is Mitomycin 40 mg used for' in discussions about treatment options.

Side Effects

Mitomycin 40 mg may cause side effects such as nausea, vomiting, or fatigue. Some patients experience low blood cell counts, which can increase infection risk. Hair loss and mouth sores are also reported in some cases. These effects vary by individual and treatment duration.

Precautions & Warnings

Mitomycin 40 mg should be handled with care, as it may cause irritation. Avoid contact with skin or eyes; use protective gloves if handling. Pregnant or breastfeeding individuals should consult a healthcare provider before use. Keep vials stored at room temperature and away from moisture.

Avoid Interactions

Mitomycin 40 mg may interact with other chemotherapy drugs or medications affecting blood cell counts. Alcohol and certain supplements could amplify side effects like nausea. Patients on blood thinners or immune suppressants should disclose this to their doctor. Always review current medications with a healthcare professional.

References

Frequently Asked Questions

Mitomycin 40 mg is used to treat certain cancers, including bladder and stomach cancer, by slowing cancer cell growth.

It is given as an injection by a healthcare professional, typically in a clinical setting.

Common side effects include nausea, fatigue, and low blood cell counts, which vary by patient.

Mitomycin 40 mg is available through prescription; consult a licensed pharmacy for availability.

Consult a healthcare provider before using Mitomycin 40 mg if pregnant or breastfeeding.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.